Safety and tolerability of liver-derived stem cells (HepaStem) infused in patients with acute-on-chronic liver failure or acute decompensation: a European phase I/IIa open-labelled study

Nevens, Frederik; Gustot, Thierry; Laterre, Pierre-François; Lasser, Luc; Haralampiev, Lyudmil Enev; Vargas, Victor; Barthel, Virginie; Clerget-Chossat, Nathalie; Sokal, Etienne

Safety and tolerability of liver-derived stem cells (HepaStem) infused in patients with acute-on-chronic liver failure or acute decompensation: a European phase I/IIa open-labelled study

Nevens, Frederik

;

Gustot, Thierry

;

Laterre, Pierre-François

;

Lasser, Luc

;

Sokal, Etienne

;et.al.

(2019) The International Liver Congress (EASL) — Location: Vienne, Autriche (11.April.2019)

Files

EASLNevens2.png

Open Access
PNG
177.9 KB

Download

Details

Authors

Nevens, FrederikKUL
Author
Gustot, Thierry
Author
Laterre, Pierre-FrançoisUCLouvain
Author
Lasser, Luc
Author
Sokal, EtienneUCLouvain
Author

Affiliations

Citations

APA
Chicago
FWB

Nevens, F., Gustot, T., Laterre, P.-F., Lasser, L., Haralampiev, L. E., Vargas, V., Barthel, V., Clerget-Chossat, N., & Sokal, E. (2019). Safety and tolerability of liver-derived stem cells (HepaStem) infused in patients with acute-on-chronic liver failure or acute decompensation: a European phase I/IIa open-labelled study. Journal of Hepatology. Supplement, 70(1), E83. https://hdl.handle.net/2078.5/88811 (Original work published 2019)